Dysthyroid optic neuropathy: evaluation and management

被引:66
作者
Dolman, P. J. [1 ]
机构
[1] Univ British Columbia, Vancouver Gen Hosp, Dept Ophthalmol & Visual Sci, Vancouver, BC, Canada
关键词
Thyroid eye disease; Graves orbitopathy; Dysthyroid optic neuropathy; Compressive optic neuropathy; Stretch optic neuropathy; Orbital decompression; GRAVES ORBITOPATHY EUGOGO; QUALITY-OF-LIFE; ORBITAL RADIOTHERAPY; EUROPEAN GROUP; TED-QOL; OPHTHALMOPATHY; DISEASE; RISK; QUESTIONNAIRE; DECOMPRESSION;
D O I
10.1007/s40618-020-01361-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Dysthyroid optic neuropathy (DON) is a serious complication of Graves orbitopathy (GO) from optic nerve dysfunction that may result in permanent loss of vision. Purpose This paper reviews the current knowledge of DON, including its pathogenesis and epidemiology, clinical and radiologic features, and management choices and outcomes. Methods Literature review and author retrospective case series. Results Over 90% of DON cases are related to nerve compression by enlarged extraocular muscles (EOM) while the remainder are caused by stretching of the optic nerve without compression. DON's incidence is 5-8% of GO cases. Risk factors include advancing age, male gender, smoking and diabetes mellitus, and these cases should be referred promptly to an ophthalmologist or GO clinic to rule out DON and for ongoing care. Clinical features of DON may include reduction in central and colour vision (unexplained by other ocular disorders), afferent pupil defect and/or optic disc edema. Since most cases are associated with enlarged EOM, restricted motility and soft tissue venous congestion are common. Visual fields and optical coherence tomography (OCT) help confirm the diagnosis while CT or MRI Scans show apical optic nerve compression or proptosis with optic nerve stretch. Standard therapy includes iv/oral corticosteroids (CS) with partial response in most cases, but often relapse with tapering. Radiotherapy may delay or avoid surgery and may prevent the onset of DON when combined with CS in high-risk individuals. The benefits of newer biologic targeted therapy are not clear. Orbital decompression surgery often has positive outcomes, even in cases of severe vision loss or delayed surgery. The most common surgical complication is worsening strabismus, which may worsen visual function and quality of life. In rare cases, permanent vision loss from DON may occur despite full therapy. Conclusions Although DON may cause vision loss, most cases are reversible if recognized and managed in a timely manner.
引用
收藏
页码:421 / 429
页数:9
相关论文
共 50 条
  • [1] Dysthyroid optic neuropathy: evaluation and management
    P. J. Dolman
    Journal of Endocrinological Investigation, 2021, 44 : 421 - 429
  • [2] Surgical management of dysthyroid optic neuropathy: A systematic review
    Meunier, A.
    Haissaguerre, M.
    Majoufre, C.
    Schlund, M.
    JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY, 2024, 125 (01)
  • [3] Dysthyroid optic neuropathy: Demographics, risk factors, investigations, and management outcomes
    Poonam, Nisar Sonam
    Alam, Md Shahid
    Oberoi, Prashant
    Mukherjee, Bipasha
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2022, 70 (12) : 4419 - 4426
  • [4] Insights into Current Management Strategies for Dysthyroid Optic Neuropathy: A Review
    Tagami, Mizuki
    Honda, Shigeru
    Azumi, Atsushi
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 841 - 850
  • [5] Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy
    Ponto, K. A.
    Diana, T.
    Binder, H.
    Matheis, N.
    Pitz, S.
    Pfeiffer, N.
    Kahaly, G. J.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2015, 38 (07) : 769 - 777
  • [6] Management of patients with dysthyroid optic neuropathy treated with intravenous corticosteroids and/or orbital decompression surgery
    Rezar-Dreindl, Sandra
    Papp, Andrea
    Baumann, Arnulf
    Neumayer, Thomas
    Eibenberger, Katharina
    Stifter, Eva
    Schmidt-Erfurth, Ursula
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (11) : 3683 - 3691
  • [7] Minimal-Access Endoscopic Endonasal Management of Dysthyroid Optic Neuropathy: The Dysthone Study
    Zah-Bi, Gilles
    Abeillon-du Payrat, Juliette
    Vie, Anne Laure
    Bournaud-Salinas, Claire
    Jouanneau, Emmanuel
    Berhouma, Moncef
    NEUROSURGERY, 2019, 85 (06) : E1059 - E1067
  • [8] Evaluation of visual evoked potentials in dysthyroid optic neuropathy
    Kuebler, Aylin Garip
    Halfter, Kathrin
    Reznicek, Lukas
    Klingenstein, Annemarie
    Priglinger, Siegfried
    Rudolph, Gunther
    Hintschich, Christoph
    ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2023, 42 (05): : 475 - 480
  • [9] Multiparametric quantitative MRI for the evaluation of dysthyroid optic neuropathy
    Zou, Mengsha
    Wu, Dide
    Zhu, Hongzhang
    Huang, Xiahua
    Zhao, Xiaojuan
    Zhao, Jing
    Fu, Wenhao
    Li, Ruocheng
    Li, Bin
    Wan, Pengxia
    Hong, Shubin
    Li, Yanbing
    Xiao, Haipeng
    Yang, Zhiyun
    EUROPEAN RADIOLOGY, 2022, 32 (03) : 1931 - 1938
  • [10] Commentary: Dysthyroid optic neuropathy
    Rath, Suryasnata
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2022, 70 (12) : 4426 - 4428